Clinical and Translational Research
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2555-2570
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2555
Figure 2
Figure 2 Kaplan-meter survival curves of 7 N6-methyladenosine regulators with differences in Epstein-Barr virus-associated gastric cancer. A: Heterogeneous nuclear ribonucleoprotein A2B1; B: Insulin like growth factor 2 binding protein 1; C: Insulin like growth factor binding protein 1; D: Leucine rich pentatricopeptide repeat containing; E: RNA Binding Motif Protein 15B; F: CBL proto-oncogene like 1; G: Wilms tumor 1 associated protein. HNRNPA2B1: Heterogeneous nuclear ribonucleoprotein A2B1; IGF2BP1: Insulin like growth factor 2 binding protein 1; IGFBP1: Insulin like growth factor binding protein 1; LRPPRC: Leucine rich pentatricopeptide repeat containing; RBM15B: RNA Binding Motif Protein 15B; CBLL1: CBL proto-oncogene like 1; WTAP: Wilms tumor 1 associated protein.